Advances in therapy

Keyphrases

Publications

volume 40, number 3, 2023

Rebecca Gall, Neal Jain, Weily Soong, Russell A Settipane, Changming Xia, Yi Zhang, Tmirah Haselkorn, Juby A Jacob-Nara, Shahid Siddiqui
Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry. Advances in therapy 40 (3) (2023)
Min Huang, Peter A Fasching, Amin Haiderali, Weiguang Xue, Chelsey Yang, Wilbur Pan, Zheng-Yi Zhou, Peter Hu, Mitashri Chaudhuri, Celine Le Bailly De Tilleghem, Nicolas Cappoen, Joyce O'Shaughnessy
Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States. Advances in therapy 40 (3) (2023)
James F Neuenschwander, Alison R Silverstein, Christie L Teigland, Shambhavi Kumar, Edric Y Zeng, Abiy T Agiro, William J Pottorf, W Frank Peacock
The Increased Clinical and Economic Burden of Hyperkalemia in Medicare Patients Admitted to Long-Term Care Settings. Advances in therapy 40 (3) (2023)
Bora Youn, Crystal M Proud, Nasha Wang, Qiang Hou, Emma Viscidi, Susan Eaton, Angela D Paradis, Bridget A Neville, Nicole B Johnson
Examining Real-World Adherence to Nusinersen for the Treatment of Spinal Muscular Atrophy Using Two Large US Data Sources. Advances in therapy 40 (3) (2023)
Dong W Kim, Yousun Lee, Geuntae Kim, Sang H Kim, Dae H Cho, Jeongmin Choi, Yong H Kwon, Younjin Park, Wooree Choi, Dong Il Park
Safety and Effectiveness of SB2 (Infliximab Biosimilar) in Adult Patients with Immune-Mediated Inflammatory Diseases: A Post-Marketing Surveillance in Korea. Advances in therapy 40 (3) (2023)
Richard Perry, Abigail J Beveridge, Amy J Sears, Elisabeth R Rasmussen
Expert Consensus on Real-World Use and Consumption Patterns of a Fixed-Dose Combination Foam for Psoriasis as a Reactive Management (RM) and Proactive Management (PAM) Regimen. Advances in therapy 40 (3) (2023)
Helen H Wang, Piero Portincasa, Min Liu, David Q-H Wang
Effects of Biliary Phospholipids on Cholesterol Crystallization and Growth in Gallstone Formation. Advances in therapy 40 (3) (2023)
Sridhar Chaganti, Arie Barlev, Sophie Caillard, Sylvain Choquet, Kate Cwynarski, Anke Friedetzky, Eva González-Barca, Natalia Sadetsky, Stefan Schneeberger, Dhanalakshmi Thirumalai, Pier L Zinzani, Ralf U Trappe
Expert Consensus on the Characteristics of Patients with Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV + PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study. Advances in therapy 40 (3) (2023)
Jiangfan Li, Yan Tan, Kexin Li, Ai-Min Hui, Zhuli Wu, Pu Han, Zhen Wei, Jingjun Qiu, Lei Diao, Xuhong Wang
Effect of Food (Low and High Fat) on Pharmacokinetics of FCN-159, a Selective MEK Inhibitor, in Healthy Chinese Males. Advances in therapy 40 (3) (2023)
Richard Perry, Abigail J Beveridge, Amy J Sears, Elisabeth R Rasmussen
Expert Consensus on Real-World Use and Consumption Patterns of a Fixed-Dose Combination Foam for Psoriasis as a Reactive Management (RM) and Proactive Management (PAM) Regimen. Advances in therapy 40 (3) (2023)
James F Neuenschwander, Alison R Silverstein, Christie L Teigland, Shambhavi Kumar, Edric Y Zeng, Abiy T Agiro, William J Pottorf, W Frank Peacock
The Increased Clinical and Economic Burden of Hyperkalemia in Medicare Patients Admitted to Long-Term Care Settings. Advances in therapy 40 (3) (2023)
Tian Jiang, Aihua Li, Minlu Zhang, Zhou Zhou, Lu Wang, Xiaoqian Zhang, Yi Zhang, Qiu Zhang
Measuring Self-management Among People with Diabetes Mellitus: A Systematic Review of Patient-Reported Diabetes-Specific Instruments in English and Chinese. Advances in therapy 40 (3) (2023)
Linda Harris, Thomas O'Connell, Jonathan J Woolley, Gilbert L'Italien, Tamela Martin, Vladimir Coric, James A Moren
Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies. Advances in therapy 40 (3) (2023)
Hera Sandhu, Weiwei Xu, Anamaria-Vera Olivieri, Christopher Lübker, Inger Smith, Vasileios Antavalis
Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom. Advances in therapy 40 (3) (2023)
Nalini Vadivelu, Gopal Kodumudi, Lisa R Leffert, Doris C Pierson, Laura K Rein, Matthew S Silverman, Elyse M Cornett, Alan D Kaye
Evolving Therapeutic Roles of Nasogastric Tubes: Current Concepts in Clinical Practice. Advances in therapy 40 (3) (2023)
Tian Jiang, Aihua Li, Minlu Zhang, Zhou Zhou, Lu Wang, Xiaoqian Zhang, Yi Zhang, Qiu Zhang
Measuring Self-management Among People with Diabetes Mellitus: A Systematic Review of Patient-Reported Diabetes-Specific Instruments in English and Chinese. Advances in therapy 40 (3) (2023)
Yin Su, Jing Li, Chenguang Wang, Xunmin Zhang, Sheng Hou, Huaizu Guo, Chenhui Deng, Lun Ou, Jinwei Wang
Population Pharmacokinetics of CMAB008 (an Infliximab Biosimilar) and Remicade ® in Healthy Subjects and Patients with Moderately to Severely Active Rheumatoid Arthritis. Advances in therapy 40 (3) (2023)
Christos Chouaid, Lise Bosquet, Nicolas Girard, Anna Kron, Matthias Scheffler, Frank Griesinger, Martin Sebastian, Jose Trigo, Santiago Viteri, Craig S Knott, Bernardo Rodrigues, Nora Rahhali, Jedelyn Cabrieto, Joris Diels, Nolen J Perualila, Claudio A Schioppa, Jan Sermon, Raphael Toueg, Nicole Erdmann, Janka Mielke, Mehregan Nematian-Samani, Cristina Martin-Fernandez, Innocent Pfaira, Tracy Li, Parthiv Mahadevia, Jürgen Wolf
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations. Advances in therapy 40 (3) (2023)
Dong W Kim, Yousun Lee, Geuntae Kim, Sang H Kim, Dae H Cho, Jeongmin Choi, Yong H Kwon, Younjin Park, Wooree Choi, Dong Il Park
Safety and Effectiveness of SB2 (Infliximab Biosimilar) in Adult Patients with Immune-Mediated Inflammatory Diseases: A Post-Marketing Surveillance in Korea. Advances in therapy 40 (3) (2023)
Hera Sandhu, Weiwei Xu, Anamaria-Vera Olivieri, Christopher Lübker, Inger Smith, Vasileios Antavalis
Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom. Advances in therapy 40 (3) (2023)
Nalini Vadivelu, Gopal Kodumudi, Lisa R Leffert, Doris C Pierson, Laura K Rein, Matthew S Silverman, Elyse M Cornett, Alan D Kaye
Evolving Therapeutic Roles of Nasogastric Tubes: Current Concepts in Clinical Practice. Advances in therapy 40 (3) (2023)
Rebecca Gall, Neal Jain, Weily Soong, Russell A Settipane, Changming Xia, Yi Zhang, Tmirah Haselkorn, Juby A Jacob-Nara, Shahid Siddiqui
Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry. Advances in therapy 40 (3) (2023)
Bora Youn, Crystal M Proud, Nasha Wang, Qiang Hou, Emma Viscidi, Susan Eaton, Angela D Paradis, Bridget A Neville, Nicole B Johnson
Examining Real-World Adherence to Nusinersen for the Treatment of Spinal Muscular Atrophy Using Two Large US Data Sources. Advances in therapy 40 (3) (2023)
Evan S Sinnathamby, Peter P Issa, Logan Roberts, Haley Norwood, Kevin Malone, Harshitha Vemulapalli, Shahab Ahmadzadeh, Elyse M Cornett, Sahar Shekoohi, Alan D Kaye
Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology. Advances in therapy 40 (3) (2023)
Karl H Kuck, Reiner Leidl, Lutz Frankenstein, Thorsten Wahlers, Archita Sarmah, Pascal Candolfi, Judith Shore, Michelle Green
Cost-Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk. Advances in therapy 40 (3) (2023)
Chong Chen, Zhu Yuan, Weixia Li, Ling Fei, Liujuan Ji, Qin Huang, Shuye Zhang, Liang Chen
Complement C3 Facilitates Stratification of Stages of Chronic Hepatitis B and Signifies Development of Acute-on-Chronic Liver Failure in Acute Decompensated Cirrhosis. Advances in therapy 40 (3) (2023)
A Mark Fendrick, Philip Mease, Matthew Davis, Pankaj Patel, Wes Matthias, Dominic Nunag, Manish Mittal
Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced Therapy. Advances in therapy 40 (3) (2023)
Christos Chouaid, Lise Bosquet, Nicolas Girard, Anna Kron, Matthias Scheffler, Frank Griesinger, Martin Sebastian, Jose Trigo, Santiago Viteri, Craig S Knott, Bernardo Rodrigues, Nora Rahhali, Jedelyn Cabrieto, Joris Diels, Nolen J Perualila, Claudio A Schioppa, Jan Sermon, Raphael Toueg, Nicole Erdmann, Janka Mielke, Mehregan Nematian-Samani, Cristina Martin-Fernandez, Innocent Pfaira, Tracy Li, Parthiv Mahadevia, Jürgen Wolf
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations. Advances in therapy 40 (3) (2023)
Min Huang, Peter A Fasching, Amin Haiderali, Weiguang Xue, Chelsey Yang, Wilbur Pan, Zheng-Yi Zhou, Peter Hu, Mitashri Chaudhuri, Celine Le Bailly De Tilleghem, Nicolas Cappoen, Joyce O'Shaughnessy
Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States. Advances in therapy 40 (3) (2023)
Jeffrey S Berger, Veronica Ashton, François Laliberté, Guillaume Germain, Brahim Bookhart, Dominique Lejeune, Julien Boudreau, Patrick Lefebvre, Matthew R Weir
Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population. Advances in therapy 40 (3) (2023)
Saleh A Alqahtani, Hussain Abdulrahman Al-Omar, Ali Alshehri, Abdulmohsen Abanumay, Hana Alabdulkarim, Ali Alrumaih, Mahmoud S Eldin, Volker Schnecke
Obesity Burden and Impact of Weight Loss in Saudi Arabia: A Modelling Study. Advances in therapy 40 (3) (2023)
Ali El-Sayed Ahmad, Miriam Silaschi, Michael Borger, Vahid Seidiramool, Marwan Hamiko, Sergey Leontyev, Andreas Zierer, Mirko Doss, Christian D Etz, Peter Benedikt, Peter Bramlage, Farhad Bakhtiary
The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study. Advances in therapy 40 (3) (2023)
Jiangfan Li, Yan Tan, Kexin Li, Ai-Min Hui, Zhuli Wu, Pu Han, Zhen Wei, Jingjun Qiu, Lei Diao, Xuhong Wang
Effect of Food (Low and High Fat) on Pharmacokinetics of FCN-159, a Selective MEK Inhibitor, in Healthy Chinese Males. Advances in therapy 40 (3) (2023)
Sadayoshi Ito, Yasuyuki Okuda, Kotaro Sugimoto
Factors Associated with the Antihypertensive Effect of Esaxerenone and Serum Potassium Elevation: A Pooled Analysis of Seven Phase III Studies. Advances in therapy 40 (3) (2023)
Evan S Sinnathamby, Peter P Issa, Logan Roberts, Haley Norwood, Kevin Malone, Harshitha Vemulapalli, Shahab Ahmadzadeh, Elyse M Cornett, Sahar Shekoohi, Alan D Kaye
Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology. Advances in therapy 40 (3) (2023)
Rui Fang, Suiqiong Wang, Yongqian Liu, Jun Xu
Cost-Effectiveness Analysis of Toripalimab Plus Paclitaxel and Cisplatin as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma. Advances in therapy 40 (3) (2023)
A Mark Fendrick, Philip Mease, Matthew Davis, Pankaj Patel, Wes Matthias, Dominic Nunag, Manish Mittal
Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced Therapy. Advances in therapy 40 (3) (2023)
Karl H Kuck, Reiner Leidl, Lutz Frankenstein, Thorsten Wahlers, Archita Sarmah, Pascal Candolfi, Judith Shore, Michelle Green
Cost-Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk. Advances in therapy 40 (3) (2023)
Jeffrey S Berger, Veronica Ashton, François Laliberté, Guillaume Germain, Brahim Bookhart, Dominique Lejeune, Julien Boudreau, Patrick Lefebvre, Matthew R Weir
Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population. Advances in therapy 40 (3) (2023)
Sadayoshi Ito, Yasuyuki Okuda, Kotaro Sugimoto
Factors Associated with the Antihypertensive Effect of Esaxerenone and Serum Potassium Elevation: A Pooled Analysis of Seven Phase III Studies. Advances in therapy 40 (3) (2023)
Chong Chen, Zhu Yuan, Weixia Li, Ling Fei, Liujuan Ji, Qin Huang, Shuye Zhang, Liang Chen
Complement C3 Facilitates Stratification of Stages of Chronic Hepatitis B and Signifies Development of Acute-on-Chronic Liver Failure in Acute Decompensated Cirrhosis. Advances in therapy 40 (3) (2023)
Sridhar Chaganti, Arie Barlev, Sophie Caillard, Sylvain Choquet, Kate Cwynarski, Anke Friedetzky, Eva González-Barca, Natalia Sadetsky, Stefan Schneeberger, Dhanalakshmi Thirumalai, Pier L Zinzani, Ralf U Trappe
Expert Consensus on the Characteristics of Patients with Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV + PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study. Advances in therapy 40 (3) (2023)
Saleh A Alqahtani, Hussain Abdulrahman Al-Omar, Ali Alshehri, Abdulmohsen Abanumay, Hana Alabdulkarim, Ali Alrumaih, Mahmoud S Eldin, Volker Schnecke
Obesity Burden and Impact of Weight Loss in Saudi Arabia: A Modelling Study. Advances in therapy 40 (3) (2023)
Ali El-Sayed Ahmad, Miriam Silaschi, Michael Borger, Vahid Seidiramool, Marwan Hamiko, Sergey Leontyev, Andreas Zierer, Mirko Doss, Christian D Etz, Peter Benedikt, Peter Bramlage, Farhad Bakhtiary
The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study. Advances in therapy 40 (3) (2023)
A Mark Fendrick, Philip Mease, Matthew Davis, Pankaj Patel, Wes Matthias, Dominic Nunag, Manish Mittal
Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced Therapy. Advances in therapy 40 (3) (2023)
Helen H Wang, Piero Portincasa, Min Liu, David Q-H Wang
Effects of Biliary Phospholipids on Cholesterol Crystallization and Growth in Gallstone Formation. Advances in therapy 40 (3) (2023)
Linda Harris, Thomas O'Connell, Jonathan J Woolley, Gilbert L'Italien, Tamela Martin, Vladimir Coric, James A Moren
Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies. Advances in therapy 40 (3) (2023)
Rui Fang, Suiqiong Wang, Yongqian Liu, Jun Xu
Cost-Effectiveness Analysis of Toripalimab Plus Paclitaxel and Cisplatin as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma. Advances in therapy 40 (3) (2023)
Yin Su, Jing Li, Chenguang Wang, Xunmin Zhang, Sheng Hou, Huaizu Guo, Chenhui Deng, Lun Ou, Jinwei Wang
Population Pharmacokinetics of CMAB008 (an Infliximab Biosimilar) and Remicade ® in Healthy Subjects and Patients with Moderately to Severely Active Rheumatoid Arthritis. Advances in therapy 40 (3) (2023)
Helen H Wang, Piero Portincasa, Min Liu, David Q-H Wang
Effects of Biliary Phospholipids on Cholesterol Crystallization and Growth in Gallstone Formation. Advances in therapy 40 (3) (2023)